Faculty

Institution

Unit

Venue

David R Nelson

Senior Vice President for Health Affairs President UF Health Senior Vice President For Health Affairs UF & President UF Health

University of Florida

Affiliations

College of Medicine

Gastroenterology, Hepatology & Nutrition

David R Nelson is currently serving as a College Of Medicine Senior Vice President for Health Affairs President UF Health Senior Vice President For Health Affairs UF & President UF Health at University of Florida.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

David R Nelson

University of Florida

Senior Vice President for Health Affairs President UF Health Senior Vice President For Health Affairs UF & President UF Health

You can click a keyword to filter the displayed items

hepatology virology pharmacology medicine immunology health sciences antiviral therapy hematology viral hepatitis gastroenterology infection control respiratory medicine hepatitis liver transplantation clinical gastroenterology oncology medicinal research clinical epidemiology outcomes research liver disease digestive diseases transplantation medicine hepatocellular carcinoma medical virology pharmacotherapy clinical microbiology antiviral research antiviral drugs liver cancer venereology cancer treatment clinical transplantation transplant infectious diseases clinical evidence treatment-naive patients cancer biology therapeutic efficacy cancer care t-regulatory cell viral oncology liver transplant recipients laboratory medicine clinical immunology virus-host interactions viral pathogenesis treatment and prevention cohort studies disease progression renal function viral diagnostics viral genetics clinical investigation cytokines apoptosis innate immune system hcv-target study treatment-experienced patients united states laboratory investigation clinical pharmacology cell regulation adaptive immune system liver transplant chronic viral infections disease transmission laboratory methods sofosbuvir-containing regimens real-world experience randomized trial observational study virologic response rates immunomodulatory role sustained virologic response interferon-free therapy liver fibrosis primary biliary cirrhosis pathology pediatric obesity

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Elucidating the Association Between Direct-Acting Antivirals and Parkinson's Disease in Patients With Hepatitis C Virus Infection. Parkinsonism & Related Disorders (2024)

Pilar Hernandez-ConRaj DesaiDavid NelsonHaesuk Park

medicineparkinson's diseasedirect-acting antiviralspharmacologyneurology

Comparing Oral Medicines to Treat Hepatitis C Virus -- the Prioritize Study. (2022)

David NelsonMichael FriedMark SulkowskiDonna EvonJodi SegalAnna LokPaul Stewart_ StewartSummer Wadsworth WadsworthScott KixmillerAnquenette SloanLarry MichealMeichen DongMonika VainoriusJoy PeterKeith Muller

virologyoral healthmedicinecohort studiesprioritize studydermatologyantiviral therapypublic healthoral medicine

Concordance Between Patients and Clinicians for Reporting Symptoms Associated With Treatment for Chronic Hepatitis C During a Pragmatic Clinical Trial. GastroHep (2022)

Bryce B. ReeveLarry MichaelJoy A. PeterPaul W. StewartAnna S.-F. LokMeichen DongKen BergquistDavid R. NelsonDonna M. Evon

hepatologydiagnosisclinical practicepragmatic clinical trialmedicineveterinary medicinehealth caresymptom managementpharmacologyrespiratory medicinedisease assessmentpatient-reported outcomesrehabilitationclinical trials

Evaluation of Machine Learning Algorithms for Predicting Direct-Acting Antiviral Treatment Failure Among Patients With Chronic Hepatitis C Infection. Scientific Reports (2022)

Haesuk ParkWei-Hsuan Lo-CiganicJames HuangYonghui WuLinda HenryJoy PeterMark SulkowskiDavid R. Nelson

virologymedicinedata-driven predictionmachine learningimmunologymachine learning algorithmshealth sciences

Long-Term Follow-Up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic Prioritize Study. Clinical Gastroenterology and Hepatology (2022)

Anna S. LokJuhi MoonKenneth E. ShermanMandana KhaliliDawn FishbeinK. Rajender ReddyGiuseppe MorelliJoy PeterDavid R. NelsonBrian PearlmanLarry MichaelMichael W. FriedJodi B. SegalMark S. Sulkowski

hepatologyvirologymedicinegastroenterologysustained virologic responseinfectious diseasesclinical epidemiologylong-term follow-upclinical gastroenterologypublic healthpragmatic prioritize studyclinical research

Machine Learning Algorithms for Predicting Direct‐Acting Antiviral Treatment Failure in Chronic Hepatitis C: An Hcv‐Target Analysis. Hepatology (2022)

Haesuk ParkWei‐Hsuan Lo‐CiganicJames HuangYonghui WuLinda HenryJoy PeterMark SulkowskiDavid R. Nelson

hepatologyhematologyhcv-target analysismachine learningimmunologypharmacologyrespiratory medicinehealth sciences

Sustainable and Equivalent Improvements in Symptoms and Functional Well‐Being Following Viral Cure From Ledipasvir/Sofosbuvir Versus Elbasvir/Grazoprevir for Chronic Hepatitis C Infection: Findings From the Randomized Prioritize Trial. Journal of Viral Hepatitis (2022)

Donna M. EvonMeichen DongBryce B. ReeveJoy PeterLarry MichaelAnna S. LokDavid R. NelsonPaul W. Stewart

hepatologycontinual improvement processvirologymedicinedisease preventionclinical effectivenessequivalent improvementsviral curepharmacologyoutcomes researchsurvival analysisclinical implementationpublic healthpatient-reported outcomesclinical researchsymptom management

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The Prioritize Study. Hepatology (2021)

Mark S. SulkowskiJuhi S. MoonKenneth E. ShermanGiuseppe MorelliJama M. DarlingAndrew J. MuirMandana KhaliliDawn A. FishbeinFederico HinestrosaMitchell L. ShiffmanAdrian Di BisceglieK. Rajender ReddyBrian PearlmanAnna S. LokMichael W. FriedPaul W. StewartJoy PeterSummer WadsworthScott KixmillerAnquenette SloanMonika VainoriusPatrick M. HorneLarry MichaelMeichen DongDonna M. EvonJodi B. SegalDavid R. Nelson

hepatologyhematologyoral antiviralsmedicinecohort studiesprioritize studypharmacologyantiviral therapypublic healthrandomized controlled trials

Do Patients at High Risk for Hepatitis C Receive Recommended Testing? a Retrospective Cohort Study of Statewide Medicaid Claims Linked With Oneflorida Clinical Data. Medicine (2021)

Rahma S. MkuuElizabeth A. ShenkmanKeith E. MullerTianyao HuoRamzi G. SalloumRoniel CabreraAli ZarrinparEmmanuel ThomasSarah M. SzurekDavid R. Nelson

clinical datamedicinehigh riskprospective cohort studieshealth risk assessmentclinical epidemiologyhealth policyoutcomes researchrespiratory medicinedisease assessmentpublic healthstatewide medicaid claimsclinical researchdisease risk assessmenthealth insurance

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence. The American Journal of Gastroenterology (2021)

Philippe J. ZamorAshley BrownDouglas E. DyllaJohn F. DillonAnne F. LuetkemeyerJordan J. FeldDavid MutimerReem GhalibEric CrownSandra S. LovellYiran HuChristophe MorenoDavid R. NelsonMassimo ColomboGeorgios PapatheodoridisJuergen K. RockstrohRichard SkoienEric LawitzIra M. Jacobson

hepatologyvirologymedicinegastroenterologysuboptimal adherenceveterinary medicinepharmacologyrespiratory medicinevirologic response ratesclinical researchhealth sciences

1
2
3
4
5
31
10 / page

David R Nelson

Senior Vice President for Health Affairs President UF Health Senior Vice President For Health Affairs UF & President UF Health

University of Florida

Affiliations

College of Medicine

Gastroenterology, Hepatology & Nutrition

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

David R Nelson

University of Florida

Senior Vice President for Health Affairs President UF Health Senior Vice President For Health Affairs UF & President UF Health

You can click a keyword to filter the displayed items

Video Presentations

Notable Scholarly Works

Notable Federal Grants

Collaborators

Elucidating the Association Between Direct-Acting Antivirals and Parkinson's Disease in Patients With Hepatitis C Virus Infection. Parkinsonism & Related Disorders (2024)

Pilar Hernandez-ConRaj DesaiDavid NelsonHaesuk Park

medicineparkinson's diseasedirect-acting antiviralspharmacologyneurology

Comparing Oral Medicines to Treat Hepatitis C Virus -- the Prioritize Study. (2022)

virologyoral healthmedicinecohort studiesprioritize studydermatologyantiviral therapypublic healthoral medicine

Concordance Between Patients and Clinicians for Reporting Symptoms Associated With Treatment for Chronic Hepatitis C During a Pragmatic Clinical Trial. GastroHep (2022)

Bryce B. ReeveLarry MichaelJoy A. PeterPaul W. StewartAnna S.-F. LokMeichen DongKen BergquistDavid R. NelsonDonna M. Evon

Evaluation of Machine Learning Algorithms for Predicting Direct-Acting Antiviral Treatment Failure Among Patients With Chronic Hepatitis C Infection. Scientific Reports (2022)

Haesuk ParkWei-Hsuan Lo-CiganicJames HuangYonghui WuLinda HenryJoy PeterMark SulkowskiDavid R. Nelson

virologymedicinedata-driven predictionmachine learningimmunologymachine learning algorithmshealth sciences

Long-Term Follow-Up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic Prioritize Study. Clinical Gastroenterology and Hepatology (2022)

Anna S. LokJuhi MoonKenneth E. ShermanMandana KhaliliDawn FishbeinK. Rajender ReddyGiuseppe MorelliJoy PeterDavid R. NelsonBrian PearlmanLarry MichaelMichael W. FriedJodi B. SegalMark S. Sulkowski

Machine Learning Algorithms for Predicting Direct‐Acting Antiviral Treatment Failure in Chronic Hepatitis C: An Hcv‐Target Analysis. Hepatology (2022)

Haesuk ParkWei‐Hsuan Lo‐CiganicJames HuangYonghui WuLinda HenryJoy PeterMark SulkowskiDavid R. Nelson

hepatologyhematologyhcv-target analysismachine learningimmunologypharmacologyrespiratory medicinehealth sciences

Donna M. EvonMeichen DongBryce B. ReeveJoy PeterLarry MichaelAnna S. LokDavid R. NelsonPaul W. Stewart

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The Prioritize Study. Hepatology (2021)

hepatologyhematologyoral antiviralsmedicinecohort studiesprioritize studypharmacologyantiviral therapypublic healthrandomized controlled trials

Do Patients at High Risk for Hepatitis C Receive Recommended Testing? a Retrospective Cohort Study of Statewide Medicaid Claims Linked With Oneflorida Clinical Data. Medicine (2021)

Rahma S. MkuuElizabeth A. ShenkmanKeith E. MullerTianyao HuoRamzi G. SalloumRoniel CabreraAli ZarrinparEmmanuel ThomasSarah M. SzurekDavid R. Nelson

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence. The American Journal of Gastroenterology (2021)

hepatologyvirologymedicinegastroenterologysuboptimal adherenceveterinary medicinepharmacologyrespiratory medicinevirologic response ratesclinical researchhealth sciences

1
2
3
4
5
31
10 / page

Similar Faculty Members

Michael W. Fried

Institution

University of North Carolina at Chapel Hill

hepatology

medicine

Joseph Lim

Institution

Yale University

hepatology

public health

K. Reddy

Institution

University of Pennsylvania

digestive endoscopy

gastroenterology

Andrew J. Muir

Institution

Duke University

hepatology

medicine

Ashwani Singal

Institution

University of Louisville

hepatology

health science

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Mark Sulkowski

Institution

Johns Hopkins University

infectious diseases

virology

David T. Curiel, MD, PhD

Institution

Washington University in St. Louis

gene transfer

gene vector

Hillard M. Lazarus

Institution

Case Western Reserve University

stem cell

pathology

Kenneth Sherman, MD, PhD

Institution

University of Cincinnati

infectious diseases (medical specialty)

epidemiology

Similar Faculty Members

Michael W. Fried

Institution

University of North Carolina at Chapel Hill

hepatology

medicine

Joseph Lim

Institution

Yale University

hepatology

public health

K. Reddy

Institution

University of Pennsylvania

digestive endoscopy

gastroenterology

Andrew J. Muir

Institution

Duke University

hepatology

medicine

Ashwani Singal

Institution

University of Louisville

hepatology

health science

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Mark Sulkowski

Institution

Johns Hopkins University

infectious diseases

virology

David T. Curiel, MD, PhD

Institution

Washington University in St. Louis

gene transfer

gene vector

Hillard M. Lazarus

Institution

Case Western Reserve University

stem cell

pathology

Kenneth Sherman, MD, PhD

Institution

University of Cincinnati

infectious diseases (medical specialty)

epidemiology